Clinical deterioration during neutropenia recovery after G-CSF therapy in patient with COVID-19
Background: Granulocyte colony stimulating factors (G-CSFs) induce neutrophils proliferation and cytokines production. It has often been used to treat neutropenia without solid evidence of efficacy. It has been demonstrated that respiratory distress is associated with neutropenia recovery but not wi...
Main Authors: | Muhanad Taha, Aditi Sharma, Ayman Soubani |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Respiratory Medicine Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007120304457 |
Similar Items
-
Can COVID‐19 cause severe neutropenia?
by: Patricia López‐Pereira, et al.
Published: (2020-12-01) -
A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis
by: María Sereno, et al.
Published: (2021-08-01) -
COVID-19 in a Patient with Accidental Drug-Induced Neutropenia
by: Pascal B Meyre, et al.
Published: (2020-08-01) -
Uso do estimulante de colônia de granulócitos nas neutropenias em cães e gatos Granulocyte colony-stimulating factor use in neutropenias in dogs and cats
by: Cynthia de Assumpção Lucidi, et al.
Published: (2007-06-01) -
New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim
by: Ghidini M, et al.
Published: (2016-06-01)